Clinical Trial Update: Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated enalapril versus placebo in patients with diastolic heart failure and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Enalapril (enalapril)

Snippet

Sponsor: Wake Forest University | Conditions: Heart Failure With Preserved Ejection Fraction, Heart Failure, Congestive | Phase 3 | Status: COMPLETED